Anja Henningsson

As of October 2020, Anja Henningsson is qPharmetra’s CEO but has been Acting-CEO since February 2020. She has been part of the management team since July 2018 while helping clients with expertise in pharmacometrics, clinical pharmacology and regulatory submissions. Anja is highly engaged in people development and the qPharmetra way of working. She actively participates in our expert teams and collaborates with the client to identify key questions and fit-for-purpose solutions to support the client’s decision-making process.